Attached files
| file | filename |
|---|---|
| 10-K - 10-K - ENDOCYTE INC | v432293_10k.htm |
| EX-4.3 - EXHIBIT 4.3 - ENDOCYTE INC | v432293_ex4-3.htm |
| EX-32.1 - EXHIBIT 32.1 - ENDOCYTE INC | v432293_ex32-1.htm |
| EX-10.18 - EXHIBIT 10.18 - ENDOCYTE INC | v432293_ex10-18.htm |
| EX-31.2 - EXHIBIT 31.2 - ENDOCYTE INC | v432293_ex31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - ENDOCYTE INC | v432293_ex31-1.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statement on Form S-3ASR (No. 333-194791) and the related Prospectus, and in the Registration Statements on Form S-8 (Nos. 333-202792, 333-194366, 333-172121 and 333-190514) of Endocyte, Inc. of our reports dated March 8, 2016, with respect to the consolidated financial statements of Endocyte, Inc., and the effectiveness of internal control over financial reporting of Endocyte, Inc., included in this Annual Report (Form 10-K) for the year ended December 31, 2015.
/s/ Ernst and Young LLP
Indianapolis, Indiana
March 8, 2016